FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

702800002: Alogliptin benzoate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2014. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3006159012 Alogliptin benzoate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3006161015 Alogliptin benzoate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
790211000172117 benzoate d'alogliptine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alogliptin benzoate (substance) Is a Alogliptin false Inferred relationship Some
Alogliptin benzoate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Dipeptidyl peptidase IV inhibitor (disposition) true Inferred relationship Some
Alogliptin benzoate (substance) Is a Dipeptidyl peptidase IV inhibitor true Inferred relationship Some
Alogliptin benzoate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Alogliptin true Inferred relationship Some
Alogliptin benzoate (substance) Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Alogliptin benzoate (substance) Is a Enzyme inhibitor false Inferred relationship Some
Alogliptin benzoate (substance) Is a Pyrimidine true Inferred relationship Some
Alogliptin benzoate (substance) Is a Piperidine true Inferred relationship Some
Alogliptin benzoate (substance) Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alogliptin benzoate (substance) Inferred relationship Some
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alogliptin benzoate (substance) Inferred relationship Some
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alogliptin benzoate (substance) Inferred relationship Some
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alogliptin benzoate (substance) Inferred relationship Some 1
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Alogliptin benzoate (substance) Inferred relationship Some 1
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alogliptin benzoate (substance) Inferred relationship Some 1
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Alogliptin benzoate (substance) Inferred relationship Some 1
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Alogliptin benzoate (substance) Inferred relationship Some 1
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Alogliptin benzoate (substance) Inferred relationship Some 1
Product containing precisely alogliptin benzoate 25 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Alogliptin benzoate (substance) Inferred relationship Some 1
Product containing precisely alogliptin benzoate 12.5 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Alogliptin benzoate (substance) Inferred relationship Some 1
Product containing precisely alogliptin benzoate 6.25 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Alogliptin benzoate (substance) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 6.25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 12.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 1
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 850 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 1 g oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 12.5 mg and metformin hydrochloride 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 25 milligram and pioglitazone (as pioglitazone hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 2
Alogliptin (as alogliptin benzoate) 12.5 mg and pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 2
Product containing precisely alogliptin (as alogliptin benzoate) 12.5 milligram and pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Alogliptin benzoate (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start